[MBLX] Metabolix, Inc.
Overview
Type of security: Stock
Sector: Basic Industries
Industry: Containers/Packaging
Market Capitalization:
Exchange: NASDAQ
The data is delayed by 15 minutes.
Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max
Chart type: absolute | relative to S&P
Description: Metabolix, Inc., a bioscience company, focuses on delivering sustainable solutions to the plastics and chemicals industries. It produces a family of biopolymers found in nature called polyhydroxyalkanoates, which occur naturally in living organisms and are chemically similar to polyesters. The company offers its biopolymers under the Mirel and Mvera brand names. It is also developing biobased industrial C4 and C3 chemicals; and harnessing the renewable nature of plants to make renewable chemicals and bioenergy from crops. Metabolix, Inc. was founded in 1992 and is based in Cambridge, Massachusetts.
See how to gain 20% in 14 sec with TrendsInvesting
Fundamental Ratios
| Shares Outstanding | EPS | EPS Growth - 4 Quarters | EPS Growth - Q/Q | ||||
| EPS Growth - Y/Y | Sales Growth - 4 Quarters | 5.22% | Sales Growth - Q/Q | -24.65% | P/E | ||
| P/E To EPS Growth | P/S | P/BV | Price/Cash Per Share | ||||
| Price/Free Cash Flow | ROA | -164.88% | ROE | -206.19% | ROI | ||
| Current Ratio | 4.84 | Quick Ratio | 4.66 | Long Term Debt/Equity | Debt Ratio | 0.24 | |
| Gross Margin | 55.53% | Operating Margin | -724.09% | Net Profit Margin | -734.89% | Dividend Payout Ratio | |
| Dividend Yield |
Fundamental Data
| Cash From Financing Activities | Cash From Investing Activities | -130 K | Cash From Operating Activities | -6.66 M | Gross Profit | 560 K | |
| Net Profit | -5.84 M | Operating Profit | -5.83 M | Total Assets | 16.67 M | Total Current Assets | 15.43 M |
| Total Current Liabilities | 3.19 M | Total Debt | Total Liabilities | 3.34 M | Total Revenue | 650 K |
Technical Data
| High 52 week | 2.21 | Low 52 week | 0.25 | Last close | 0.37 | Last change | 2.78% |
| RSI | 58.06 | Average true range | 0.05 | Beta | 1.37 | Volume | 587.77 K |
| Simple moving average 20 days | 6.78% | Simple moving average 50 days | 0.33% | Simple moving average 200 days | -49.16% |
Performance Data
| Performance Week | 8.82% | Performance Month | 48% | Performance Quart | -27.45% | Performance Half | -53.75% |
| Performance Year | -74.31% | Performance Year-to-date | 5.71% | Volatility daily | 17.13% | Volatility weekly | 38.31% |
| Volatility monthly | 78.51% | Volatility yearly | 271.97% | Relative Volume | 330.21% | Average Volume | 118.05 K |
| New High | New Low |
News
2019-08-14 14:07:23 | Edited Transcript of MBLX earnings conference call or presentation 12-Aug-19 8:30pm GMT
2019-05-10 16:17:29 | Edited Transcript of MBLX earnings conference call or presentation 9-May-19 9:00pm GMT
2019-03-26 03:47:57 | Edited Transcript of MBLX earnings conference call or presentation 25-Mar-19 8:30pm GMT
2018-11-10 05:27:19 | Edited Transcript of MBLX earnings conference call or presentation 8-Nov-18 9:30pm GMT
2018-08-24 21:48:43 | Edited Transcript of MBLX earnings conference call or presentation 9-Aug-18 8:30pm GMT
2018-05-21 22:52:52 | Edited Transcript of MBLX earnings conference call or presentation 10-May-18 8:30pm GMT
2018-03-10 02:06:04 | Edited Transcript of MBLX earnings conference call or presentation 8-Mar-18 9:30pm GMT
2017-11-10 16:17:08 | Edited Transcript of MBLX earnings conference call or presentation 9-Nov-17 9:30pm GMT
2017-08-30 06:27:43 | Edited Transcript of MBLX earnings conference call or presentation 22-Mar-17 8:30pm GMT
2017-08-16 14:28:43 | Edited Transcript of MBLX earnings conference call or presentation 10-Aug-17 8:30pm GMT
2017-05-12 17:50:33 | Edited Transcript of MBLX earnings conference call or presentation 11-May-17 8:30pm GMT
2017-05-11 19:15:58 | Edited Transcript of MBLX earnings conference call or presentation 11-May-17 8:30pm GMT
2017-03-22 07:07:02 | Q4 2016 Yield10 Bioscience Inc Earnings Release - After Market Close
2017-01-06 12:55:45 | METABOLIX, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statem
2017-01-06 09:35:07 | Metabolix, Inc. Announces Name Change to Yield10 Bioscience, Inc.
2017-01-06 09:00:00 | Metabolix, Inc. Announces Name Change to Yield10 Bioscience, Inc.
2017-01-05 16:10:53 | METABOLIX, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
2017-01-04 03:53:05 | Metabolix Granted 180-day Extension by NASDAQ to Regain Compliance with Minimum Bid Price Rule
2017-01-03 16:10:03 | METABOLIX, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; T
2017-01-03 16:07:00 | 4:07 pm Metabolix announces the co was granted 180-day extension by Nasdaq to regain compliance with min bid price rule
2017-01-03 16:05:00 | Metabolix Granted 180-day Extension by NASDAQ to Regain Compliance with Minimum Bid Price Rule
2016-12-21 15:04:07 | METABOLIX, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
2016-12-19 13:39:49 | ETFs with exposure to Metabolix, Inc. : December 19, 2016
2016-12-09 12:25:26 | ETFs with exposure to Metabolix, Inc. : December 9, 2016
2016-11-18 13:07:06 | METABOLIX, INC. Files SEC form 10-Q, Quarterly Report
2016-11-16 13:15:47 | ETFs with exposure to Metabolix, Inc. : November 16, 2016
2016-11-11 12:00:03 | Metabolix, Inc. :MBLX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016
2016-11-09 16:21:22 | Metabolix Announces Third Quarter 2016 Financial Results
2016-11-09 16:13:01 | METABOLIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
2016-11-09 16:05:00 | Metabolix Announces Third Quarter 2016 Financial Results
2016-11-09 07:07:08 | Q3 2016 Metabolix Inc Earnings Release - After Market Close
2016-11-08 16:13:50 | METABOLIX, INC. Files SEC form 8-K, Change in Directors or Principal Officers
2016-11-01 09:15:06 | Metabolix to Conduct Webcast of its Third Quarter Conference Call
2016-11-01 09:00:00 | Metabolix to Conduct Webcast of its Third Quarter Conference Call
2016-10-27 13:27:14 | ETF’s with exposure to Metabolix, Inc. : October 27, 2016
2016-10-19 16:28:06 | METABOLIX, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial St
2016-10-17 16:33:06 | Metabolix Names Yield10 Bioscience Management Team; Provides Update on Strategic Restructuring and Cash Position
2016-10-17 16:33:06 | Metabolix to Conduct Conference Call and Live Webcast of Investor Presentation on Yield10 Bioscience
2016-10-17 16:06:00 | Metabolix to Conduct Conference Call and Live Webcast of Investor Presentation on Yield10 Bioscience
2016-10-17 16:05:00 | Metabolix Names Yield10 Bioscience Management Team; Provides Update on Strategic Restructuring and Cash Position
2016-10-06 11:33:18 | Dr. Kristi Snell Representing Yield10 at Policy Event Focused on Building a 21st Century Agricultural Workforce
2016-10-04 10:06:14 | ETF’s with exposure to Metabolix, Inc. : October 4, 2016
2016-09-29 09:10:10 | Metabolix and North Carolina State University Enter into Worldwide, Exclusive License Agreement for Advanced Crop Technologies
2016-09-29 09:00:00 | Metabolix and North Carolina State University Enter into Worldwide, Exclusive License Agreement for Advanced Crop Technologies
2016-09-27 09:19:02 | Metabolix Names Heike Sederoff, Ph.D. to Yield10 Bioscience Scientific Advisory Board
2016-09-27 09:00:00 | Metabolix Names Heike Sederoff, Ph.D. to Yield10 Bioscience Scientific Advisory Board
2016-09-21 16:07:15 | METABOLIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial S
2016-09-19 16:18:08 | Metabolix Completes $10 Million Sale of Biopolymer Assets to CJ CheilJedang
2016-09-19 16:05:00 | Metabolix Completes $10 Million Sale of Biopolymer Assets to CJ CheilJedang
2016-08-22 16:28:08 | Metabolix Announces $10 Million Binding Letter of Intent for Sale of Biopolymer Assets to CJ CheilJedang